MENTOR (2019) — Trial Summary

MENTOR (2019): Rituximab was noninferior to cyclosporine in inducing complete or partial remission of proteinuria in patients with membranous nephropathy and was superior in maintaining proteinuria remission at 24 months.

References

NephroResource

Taking longer than expected

If you're on a slow connection or this keeps happening, tap below to reload.